Mission Produce's Inflection Needs One Thing It Doesn't Have Yet: Cash Flow

Mission Produce booked its biggest revenue quarter on record and the stock jumped about 8% after hours, and yet the company still lost money. That contradiction is the whole story in miniature: the market read straight through a per-share loss to what it saw underneath, which is an avocado distributor that just used a big acquisition to stop being what it was.

For the past couple of years, Mission Produce (AVO) looked like a one-crop commodity business at the mercy of a Mexican supply glut. Roughly 85% of revenue comes from avocados, and when growers flooded the market, per-pound prices collapsed and took margins down with them. Last fiscal year the company earned just $0.53 a share, and even a quarter that beat expectations sent the stock down 7% when management warned it saw weaker prices ahead. That is the old story, and it is why the shares spent 2025's slide near $10 to $11, well off the 52-week high of $15.53.

The thing that made that story stale closed on May 28. That day Mission completed its acquisition of Calavo Growers for roughly $267 million in cash plus about 17.5 million shares, a deal that adds prepared foods, a wider product line, and distribution reach. To fund it, Mission borrowed heavily — long-term debt went from around $96 million at the end of fiscal 2025 to roughly $400 million. The bet is that a bigger, more diversified North American produce platform is worth more than a stand-alone avocado trade.

The fiscal third quarter, ended July 31, shows the deal working at the top line even as the old price problem lingers. Revenue rose 26% to $450.0 million, well above the $371 million analysts expected, on avocado volume up 38% to 253 million pounds. But the average price fell 9% to $1.58 a pound, so gross margin dropped to 9.9% and adjusted EBITDA came in nearly flat at $32.4 million. Adjusted earnings of $0.18 a share beat the $0.12 consensus; the headline number was a $0.08 loss because the quarter carried $25.4 million of one-time Calavo and integration costs.

Here is the turn. The market did not celebrate the flat adjusted EBITDA; it celebrated that volume is climbing even while price falls. That points to a platform that is expanding for reasons that have nothing to do with the price cycle. It is the reason management raised its annualized Calavo synergy target from "at least $25 million" to "more than $30 million," citing better-than-expected cost savings and network efficiencies. It is also the reason Mission guided fourth-quarter adjusted EBITDA to roughly $52 million to $55 million — a jump of well over half on top of the third quarter, driven by the Peru harvest season, a full quarter of Calavo, and the first synergy contributions. The company reaffirmed its second-half target of $84 million to $88 million.

Now the part I have to be honest about. My preferred hard proof — free cash flow — is not there yet. It is the opposite of there: operating cash flow was negative $25.9 million for the first nine months, versus positive $21.4 million a year earlier, as working capital and Calavo costs piled up, and trailing free cash flow is roughly flat-to-negative. So this case is not yet carried by cash that has landed. It is carried by an adjusted-EBITDA guide and by the expectation that the heavier debt load gets paid down as the working-capital build unwinds. That is a real bridge, but it is a higher-uncertainty one, and it is the first place the story can break.

The market is still partly pricing the old risk profile — a commodity distributor squeezed by cheap avocados — while the operating setup is already getting cleaner on volume and scale. AInvest's aggregate signal labels the stock a Buy, a crowd that is warming to the same read-through. But the rerating only holds if the numbers keep arriving: if Mission delivers the $84 million to $88 million in second-half EBITDA, if the Calavo synergies actually show up in the P&L starting this quarter and building through fiscal 2027, and if cash flow turns positive as the working-capital bulge flushes through. The condition that would break it is concrete — a miss on that EBITDA guide, or avocado prices so depressed that volume growth can no longer cover the gap.

I can be wrong again; integration is where deals like this usually stumble. But the direction of travel is no longer up for debate the way it was a year ago. Mission is not asking you to believe prices recover. It is asking you to watch volume, scale, and eventually free cash flow do the work instead. That is the more forgiving bet — and the honest one.